ACOG低剂量阿司匹林指南对慢性高血压孕妇重叠子痫前期预防的影响
本研究回顾性分析2014年1月至2018年6月在托马斯杰斐逊大学医院分娩的457例慢性高血压孕妇,比较ACOG 2016年指南发布前后重叠子痫前期发生率。指南后70%孕妇接受81mg阿司匹林,但重叠子痫前期总发生率无显著差异(34.3% vs 35.5%,P=.79),伴严重特征的重叠子痫前期显著增加(12.6% vs 4.4%,P<.01),不伴严重特征者显著减少(21.7% vs 31.0%,P=.03)。
要点
- 指南后81mg阿司匹林使用率从7.0%升至70%,但重叠子痫前期总发生率未显著下降。
- 伴严重特征的重叠子痫前期显著增加(12.6% vs 4.4%,P<.01)。
- 不伴严重特征的重叠子痫前期显著减少(21.7% vs 31.0%,P=.03)。
核心结论
- 在70%队列采纳ACOG指南后,妊娠12-16周启动81mg阿司匹林未显著降低重叠子痫前期、小于胎龄儿和37周前早产的发生率。
研究设计与样本
- 回顾性研究,纳入2014年1月至2018年6月在托马斯杰斐逊大学医院分娩的457例慢性高血压孕妇,分为ACOG 2016年9月指南发布前组(254例)和后组(203例)。
- 排除多胎妊娠和记录不完整者,阿司匹林81mg于妊娠12-16周启动。
主要发现
- 指南后组142例(70%)接受阿司匹林81mg,指南前组18例(7.0%)。
- 重叠子痫前期总发生率:指南前组87例(34.3%) vs 指南后组72例(35.5%),P=.79。
- 伴严重特征的重叠子痫前期:指南前组32例(12.6%) vs 指南后组9例(4.4%),P<.01。
- 不伴严重特征的重叠子痫前期:指南前组55例(21.7%) vs 指南后组63例(31.0%),P=.03。
- 小于胎龄儿和37周前早产发生率组间无显著差异;基于需要降压药、子痫前期病史或孕前糖尿病的亚组分析无显著差异。
关键数值与推荐
- 2016年ACOG指南推荐所有慢性高血压孕妇每日启动81mg阿司匹林以预防重叠子痫前期。
- 本研究阿司匹林81mg于妊娠12-16周启动。
临床怎么用
- 慢性高血压孕妇应遵循指南评估并启动低剂量阿司匹林,但需认识到本研究未显示重叠子痫前期总发生率显著降低。
- 伴严重特征的重叠子痫前期在指南后增加,临床需加强监测。
局限性
- 回顾性研究设计。
- 单中心研究。
- 指南后组仅70%接受阿司匹林。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with chronic hypertension are at increased risk for superimposed preeclampsia. The 2016 American College of Obstetricians and Gynecologists guideline recommended initiating 81 mg of daily aspirin for all pregnant women with chronic hypertension to prevent superimposed preeclampsia. OBJECTIVE: (1) To evaluate the rates of implementation of the 2016 American College of Obstetricians and Gynecologists guideline over time; and (2) to evaluate the effectiveness of aspirin for the prevention of superimposed preeclampsia and other adverse maternal and neonatal outcomes in women with chronic hypertension before and after this guideline. STUDY DESIGN: This is a retrospective study of women with chronic hypertension who delivered at Thomas Jefferson University Hospital from January 2014 through June 2018. This cohort of women with chronic hypertension was divided into 2 groups, before and after the American College of Obstetricians and Gynecologists recommendation published in September 2016. Daily 81 mg of aspirin was initiated between 12 and 16 weeks. We excluded multiple gestations and incomplete records. The primary outcome was incidence of superimposed preeclampsia, and secondary outcomes were incidence of superimposed preeclampsia with or without severe features, small for gestational age, and preterm birth <37 weeks. Subgroup analysis based on risk stratification was evaluated in women with chronic hypertension requiring antihypertensive medication, history of preeclampsia, and pregestational diabetes. RESULTS: We identified 457 pregnant women with chronic hypertension, 203 in the post-American College of Obstetricians and Gynecologists group and 254 in the pre-American College of Obstetricians and Gynecologists group. Aspirin 81 mg was offered to 142 (70%) in the post-American College of Obstetricians and Gynecologists group and 18 (7.0%) in the pre-American College of Obstetricians and Gynecologists group. Maternal demographics were not significantly different. The overall incidence of superimposed preeclampsia was not significantly different: 87 (34.3%) vs 72 (35.5%), P=.79, in the pre- and post-American College of Obstetricians and Gynecologists guideline groups, respectively. Superimposed preeclampsia with severe features significantly increased: 32 (12.6%) vs 9 (4.4%), P<.01, whereas superimposed preeclampsia without severe features significantly decreased: 55 (21.7%) vs 63 (31.0%), P=.03. There were no significant differences in small for gestational age neonates or preterm birth <37 weeks incidences between groups. There were no significant differences in the subgroup analysis based on the severity of chronic hypertension requiring antihypertensive medication, history of preeclampsia, or pregestational diabetes. CONCLUSION: After the adoption of the American College of Obstetricians and Gynecologists guidelines in 70% of the cohort, superimposed preeclampsia, small for gestational age, and preterm birth were not significantly decreased after implementation of aspirin 81 mg initiated between 12 and 16 weeks of gestation.
引用
- Banala C, Moreno S, Cruz Y, et al. Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension. Am J Obstet Gynecol. 2020. PMID: 32173446. doi:10.1016/j.ajog.2020.03.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。